Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aoxin Q & M Dental GroupSGX:1D4 55 FCF Margin % is 3.82% as of Dec. 2025, which is 39% below its 10-year median of 6.26. GuruFocus rates SGX:1D4 with a GF Score™ of 55/100 and a GF Value™ of S$0.05 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 667 Healthcare Providers & Services companies, Aoxin Q & M Dental Group ranks worse than 56.07% on this metric.
The historical rank and industry rank for Aoxin Q & M Dental Group's FCF Margin % or its related term are showing as below:
SGX:1D4'
s FCF Margin % Range Over the Past 10 Years
Min: -30.7 Med: 6.26 Max: 15.8
Current: 1.16
During the past 13 years, the highest FCF Margin % of Aoxin Q & M Dental Group was 15.80%. The lowest was -30.70%. And the median was 6.26%.
SGX:1D4's FCF Margin % is ranked worse than 56.07% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 3.12
vs SGX:1D4: 1.16
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Aoxin Q & M Dental Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aoxin Q & M Dental Group FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aoxin Q & M Dental Group's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Aoxin Q & M Dental Group's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aoxin Q & M Dental Group (SGX:1D4) has a FCF Margin % of 3.82% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aoxin Q & M Dental Group and its competitors. This is 39% below median its historical median of 6.26. According to the industry distribution chart, Aoxin Q & M Dental Group ranks #374 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 56.1%.
Is Aoxin Q & M Dental Group's FCF Margin % too high?
Aoxin Q & M Dental Group's current FCF Margin % of 3.82% is 39% below median its 10-year median of 6.26. The Healthcare Providers & Services industry median FCF Margin % is 3.12. Aoxin Q & M Dental Group's value of 3.82% is 22.4% above this industry median. Based on the distribution chart, Aoxin Q & M Dental Group ranks #374 out of 667 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Aoxin Q & M Dental Group has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aoxin Q & M Dental Group's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aoxin Q & M Dental Group ranks #374 out of 667 companies for FCF Margin %. This places Aoxin Q & M Dental Group in the lower half of its industry. The industry median FCF Margin % is 3.12. Aoxin Q & M Dental Group's value of 3.82% is 22.4% above this benchmark. While the company's 10-year median is 6.26 vs. the industry median of 3.12, Aoxin Q & M Dental Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.12, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aoxin Q & M Dental Group's current FCF Margin % of 3.82% is 22.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aoxin Q & M Dental Group and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aoxin Q & M Dental Group's current FCF Margin % is 3.82%, which is 39% below median its own 10-year median of 6.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aoxin Q & M Dental Group stock overvalued right now?
Based on GuruFocus' analysis, Aoxin Q & M Dental Group (SGX:1D4) is currently considered Significantly Overvalued. The stock's GF Value™ is S$0.05, compared to a current price of S$0.24 — trading 380% above its estimated fair value. The current FCF Margin % is 3.82%, which is 39% below median its 10-year median of 6.26 and 22.4% above the Healthcare Providers & Services industry median of 3.12. Aoxin Q & M Dental Group's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Aoxin Q & M Dental Group (SGX:1D4), the current FCF Margin % is 3.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aoxin Q & M Dental Group (SGX:1D4) Overvalued in 2026?
Based on GuruFocus' analysis, Aoxin Q & M Dental Group stock appears to be overvalued.
The current stock price of S$0.24 is trading 380% above its estimated GF Value™ of S$0.05.
GuruFocus considers Aoxin Q & M Dental Group to be Significantly Overvalued.
Key valuation signals for SGX:1D4:
FCF Margin %: 3.82% (39% below median its 10-year median of 6.26)
GF Value™: S$0.05 vs. price of S$0.24 (380% above fair value)
Industry Position: 22.4% above the Healthcare Providers & Services median (#374 of 667)
No single metric tells the full story. See the SGX:1D4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aoxin Q & M Dental Group Ltd, along with its subsidiaries, offers private dental services, dental equipment, and supplies. The various dental care services offered by the Group include Stomatology and general dentistry, Endodontics, Orthodontics, Periodontics, Dental implantology, and many more. Its dental equipment and supplies portfolio includes dental chairs, ultrasound scanners, dental instruments, materials, and consumables for dental hospitals, clinics, distributors, and laboratories. The Group's reportable operating segments are: Primary healthcare, which generates the maximum revenue, Distribution of dental equipment and supplies, and Laboratory services. Geographically, it generates maximum revenue from the People's Republic of China (PRC) and the rest from Singapore.
55GF Score
Get the complete analysis for SGX:1D4
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1D4 has been successfully added to your 
